Results
|
|
141.
|
Response to tyrosine kinase inhibitor therapy in patients with chronic myelogenous leukemia relapsing in chronic and advanced phase following allogeneic hematopoietic stem cell transplantation. [electronic resource] by
- Wright, Matthew P
- Shepherd, John D
- Barnett, Michael J
- Nantel, Stephen H
- Sutherland, Heather J
- Toze, Cynthia L
- Hogge, Donna E
- Nevill, Thomas J
- Song, Kevin W
- Abou Mourad, Yasser R
- Narayanan, Sujaatha
- Power, Maryse M
- Smith, Clayton A
- Forrest, Donna L
Producer: 20100813
In:
Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation vol. 16
Availability: No items available.
|
|
|
142.
|
A phase I study of danusertib (PHA-739358) in adult patients with accelerated or blastic phase chronic myeloid leukemia and Philadelphia chromosome-positive acute lymphoblastic leukemia resistant or intolerant to imatinib and/or other second generation c-ABL therapy. [electronic resource] by
- Borthakur, Gautam
- Dombret, Herve
- Schafhausen, Philippe
- Brummendorf, Tim Henrik
- Boissel, Nicolas
- Jabbour, Elias
- Mariani, Mariangela
- Capolongo, Laura
- Carpinelli, Patrizia
- Davite, Cristina
- Kantarjian, Hagop
- Cortes, Jorge E
Producer: 20160209
In:
Haematologica vol. 100
Availability: No items available.
|
|
|
143.
|
Allogeneic Stem Cell Transplantation for Patients with T315I BCR-ABL Mutated Chronic Myeloid Leukemia. [electronic resource] by
- Xu, Lan-Ping
- Xu, Zheng-Li
- Zhang, Xiao-Hui
- Chen, Huan
- Chen, Yu-Hong
- Han, Wei
- Chen, Yao
- Wang, Feng-Rong
- Wang, Jing-Zhi
- Wang, Yu
- Yan, Chen-Hua
- Mo, Xiao-Dong
- Liu, Kai-Yan
- Huang, Xiao-Jun
Producer: 20180212
In:
Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation vol. 22
Availability: No items available.
|
|
|
144.
|
Cytogenetic and molecular responses to standard-dose imatinib in chronic myeloid leukemia are correlated with Sokal risk scores and duration of therapy but not trough imatinib plasma levels. [electronic resource] by
- Forrest, Donna L
- Trainor, Shannon
- Brinkman, Ryan R
- Barnett, Michael J
- Hogge, Donna E
- Nevill, Thomas J
- Shepherd, John D
- Nantel, Stephen H
- Toze, Cynthia L
- Sutherland, Heather J
- Song, Kevin W
- Lavoie, Julye C
- Power, Maryse M
- Abou-Mourad, Yasser
- Smith, Clayton A
Producer: 20090227
In:
Leukemia research vol. 33
Availability: No items available.
|
|
|
145.
|
|
|
|
146.
|
Sequential treatment of Ph-positive chronic myeloid leukemia with interferon gamma and interferon alpha. [electronic resource] by
- Russo, D
- Fanin, R
- Zuffa, E
- Damiani, D
- Gallizia, C
- Michieli, M
- Testoni, N
- Benfenati, D
- Visani, G
- Zaccaria, A
Producer: 19910307
In:
Haematologica vol. 75
Availability: No items available.
|
|
|
147.
|
Nilotinib (formerly AMN107), a highly selective BCR-ABL tyrosine kinase inhibitor, is active in patients with imatinib-resistant or -intolerant accelerated-phase chronic myelogenous leukemia. [electronic resource] by
- le Coutre, Philipp
- Ottmann, Oliver G
- Giles, Francis
- Kim, Dong-Wook
- Cortes, Jorge
- Gattermann, Norbert
- Apperley, Jane F
- Larson, Richard A
- Abruzzese, Elisabetta
- O'Brien, Stephen G
- Kuliczkowski, Kazimierz
- Hochhaus, Andreas
- Mahon, Francois-Xavier
- Saglio, Giuseppe
- Gobbi, Marco
- Kwong, Yok-Lam
- Baccarani, Michele
- Hughes, Timothy
- Martinelli, Giovanni
- Radich, Jerald P
- Zheng, Ming
- Shou, Yaping
- Kantarjian, Hagop
Producer: 20080521
In:
Blood vol. 111
Availability: No items available.
|
|
|
148.
|
Expanding Nilotinib Access in Clinical Trials (ENACT), an open-label multicenter study of oral nilotinib in adult patients with imatinib-resistant or -intolerant chronic myeloid leukemia in accelerated phase or blast crisis. [electronic resource] by
- Nicolini, Franck E
- Masszi, Tamas
- Shen, Zhixiang
- Gallagher, Neil J
- Jootar, Saengsuree
- Powell, Bayard L
- Dorlhiac-Llacer, Pedro Enrique
- Zheng, Ming
- Szczudlo, Tomasz
- Turkina, Anna
Producer: 20121029
In:
Leukemia & lymphoma vol. 53
Availability: No items available.
|
|
|
149.
|
|
|
|
150.
|
|
|
|
151.
|
|
|
|
152.
|
Autologous blood stem cell transplantation followed by recombinant alpha interferon as treatment for patients with high-risk chronic myelogenous leukemia. A report of 32 cases. [electronic resource] by
- Reiffers, J
- Montastruc, M
- Marit, G
- Cony-Makhoul, P
- Faberes, C
- Bilhou-Nabera, C
- Gharbi, M J
- Bernard, P
- Vezon, G
- Broustet, A
Producer: 19940107
In:
Leukemia & lymphoma vol. 11 Suppl 1
Availability: No items available.
|
|
|
153.
|
Increase of bcr-abl chimeric mRNA expression in tumor cells of patients with chronic myeloid leukemia precedes disease progression. [electronic resource] by
- Gaiger, A
- Henn, T
- Hörth, E
- Geissler, K
- Mitterbauer, G
- Maier-Dobersberger, T
- Greinix, H
- Mannhalter, C
- Haas, O A
- Lechner, K
- Lion, T
Producer: 19951012
In:
Blood vol. 86
Availability: No items available.
|
|
|
154.
|
Interphase cytogenetics and competitive RT-PCR for residual disease monitoring in patients with chronic myeloid leukaemia during interferon-alpha therapy. [electronic resource] by
- Tchirkov, A
- Giollant, M
- Tavernier, F
- Briançon, G
- Tournilhac, O
- Kwiatkowski, F
- Philippe, P
- Choufi, B
- Deméocq, F
- Travade, P
- Malet, P
Producer: 19980731
In:
British journal of haematology vol. 101
Availability: No items available.
|
|
|
155.
|
Tyrosine kinase inhibitors as initial therapy for patients with chronic myeloid leukemia in accelerated phase. [electronic resource] by
- Ohanian, Maro
- Kantarjian, Hagop M
- Quintas-Cardama, Alfonso
- Jabbour, Elias
- Abruzzo, Lynne
- Verstovsek, Srdan
- Borthakur, Gautam
- Ravandi, Farhad
- Garcia-Manero, Guillermo
- Champlin, Richard
- Pierce, Sherry
- Alattar, Mona Lisa
- Trinh, Long Xuan
- Luthra, Raja
- Ferrajoli, Alessandra
- Kadia, Tapan
- O'Brien, Susan
- Cortes, Jorge E
Producer: 20141124
In:
Clinical lymphoma, myeloma & leukemia vol. 14
Availability: No items available.
|
|
|
156.
|
|
|
|
157.
|
|
|
|
158.
|
|
|
|
159.
|
A successful cord blood transplant in a child with second accelerated phase chronic myeloid leukemia following lymphoid blast crisis. [electronic resource] by
- Maschan, A A
- Skorobogatova, E V
- Samotchatova, E V
- Balashov, D N
- Yourlova, M I
- Bogatcheva, N I
- Pashanov, E D
- Trakhtman, P E
- Timakov, A M
- Rumiantzev, A G
Producer: 20000320
In:
Bone marrow transplantation vol. 25
Availability: No items available.
|
|
|
160.
|
Failure to achieve a complete hematologic response at the time of a major cytogenetic response with second-generation tyrosine kinase inhibitors is associated with a poor prognosis among patients with chronic myeloid leukemia in accelerated or blast phase. [electronic resource] by
- Fava, Carmen
- Kantarjian, Hagop M
- Jabbour, Elias
- O'Brien, Susan
- Jain, Nitin
- Rios, Mary Beth
- Garcia-Manero, Guillermo
- Ravandi, Farhad
- Verstovsek, Srdan
- Borthakur, Gautam
- Shan, Jianqin
- Cortes, Jorge
Producer: 20090617
In:
Blood vol. 113
Availability: No items available.
|